{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:08:58Z","timestamp":1789978138850,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.leukres.2003.09.015","type":"journal-article","created":{"date-parts":[[2003,12,9]],"date-time":"2003-12-09T11:55:53Z","timestamp":1070970953000},"page":"469-477","source":"Crossref","is-referenced-by-count":52,"title":["Flow cytometric detection of aneuploid CD38++ plasmacells and CD19+ B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients"],"prefix":"10.1016","volume":"28","author":[{"given":"Anna Maria","family":"Santonocito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bagnato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe A.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Di","family":"Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Stagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Guglielmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Giustolisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2003.09.015_BIB1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB2","first-page":"24","article-title":"Advances in the diagnosis and management of myeloma","volume":"29","author":"Greipp","year":"1992","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.1994.tb03271.x","article-title":"Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration","volume":"86","author":"Vora","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB4","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1182\/blood.V87.4.1625.bloodjournal8741625","article-title":"Concomitant mobilization of plasmacells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells","volume":"87","author":"Lemoli","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","article-title":"Gene marking to trace the origin of relapse after autologous bone marrow transplantation","volume":"341","author":"Brenner","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2003.09.015_BIB6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2141.1994.tb06732.x","article-title":"Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies","volume":"87","author":"Takishita","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V85.2.436.436","article-title":"In multiple myeloma, clonotypic B-lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56 and monotypic Ig light chain","volume":"85","author":"Bergsagel","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB8","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1182\/blood.V86.10.4000.bloodjournal86104000","article-title":"Circulating CD19+ blood cell levels in myeloma","volume":"86","author":"Kay","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB9","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood.V70.5.1550.1550","article-title":"Evidence for peripheral blood B-lymphocytes but not T lymphocyte involvement in multiple myeloma","volume":"70","author":"Berenson","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2141.1997.72653.x","article-title":"Circulating plasmacells in multiple myeloma: characterization and correlation with disease stage","volume":"97","author":"Rawstron","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.1989.tb07646.x","article-title":"Circulating monoclonal B-lymphocytes in multiple myeloma","volume":"72","author":"Chiu","year":"1989","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2141.1990.tb02643.x","article-title":"Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B lymphocyte clones in a polyclonal population","volume":"75","author":"Brisco","year":"1990","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB13","first-page":"333","article-title":"Membrane CD22 defines circulating myeloma-related cells as mature or later B cells","volume":"77","author":"Perfetti","year":"1997","journal-title":"Lab. Invest."},{"key":"10.1016\/j.leukres.2003.09.015_BIB14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI112080","article-title":"Identification of malignant plasmacells precursors in the bone marrow of multiple myeloma","volume":"76","author":"Caligaris-Cappio","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2003.09.015_BIB15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood.V71.4.861.861","article-title":"Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement","volume":"71","author":"Epstein","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V55.3.403.403","article-title":"Cellular DNA content as a marker of human multiple myeloma","volume":"55","author":"Latreille","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0950-3536(05)80257-4","article-title":"Immunophenotype and DNA content in multiple myeloma","volume":"8","author":"San Miguel","year":"1995","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1995.tb03387.x","article-title":"Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients","volume":"90","author":"Garcia-Sanz","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB19","unstructured":"Chronic Leukemia-Myeloma Task Force, National Cancer Institute Proposed guidelines for protocol studies. II. Plasmacell myeloma. Cancer Chemother Rep 1973;4:145\u201358."},{"issue":"4","key":"10.1016\/j.leukres.2003.09.015_BIB20","first-page":"309","article-title":"A new flow cytometric approach to the analysis of DNA and an second parameter","volume":"18","author":"Kusuda","year":"1996","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0320(19990501)36:1<71::AID-CYTO9>3.0.CO;2-R","article-title":"Detection of residual aneuploid leukemic cells by \u201ccontinuous gating\u201d","volume":"36","author":"Kleine","year":"1999","journal-title":"Cytometry"},{"key":"10.1016\/j.leukres.2003.09.015_BIB22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0091-679X(08)60076-X","article-title":"Methods and application of flow systems for analysis and sorting of mammalian cell","volume":"9","author":"Crissman","year":"1975","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0197-1859(91)90002-A","article-title":"Applications of flow cytometry to solid tumors","volume":"11","author":"Coon","year":"1991","journal-title":"Clin. Immunol. Newsl."},{"key":"10.1016\/j.leukres.2003.09.015_BIB24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1987.5.10.1690","article-title":"Flow cytometry, cellular DNA content, and prognosis in human malignancy","volume":"5","author":"Merkel","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB25","first-page":"3982","article-title":"Flow cytometry in clinical cancer research","volume":"43","author":"Barlogie","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2003.09.015_BIB26","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood.V81.10.2658.2658","article-title":"Phenotipic difference of normal plasmacell from mature myeloma cells","volume":"81","author":"Harada","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB27","first-page":"351","article-title":"An analysis of myeloma plasmacell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens","volume":"72","author":"Jackson","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB28","first-page":"5010","article-title":"Cellular DNA of human neoplastic B cells measured by flow cytometry","volume":"44","author":"Braylan","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2003.09.015_BIB29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000204846","article-title":"Detection of minimal residual myeloma cells by dual parameter analysis of DNA and cytoplasmic immunoglobulin","volume":"85","author":"Shimazaki","year":"1991","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cyto.990170409","article-title":"A new method for the analysis of plasmacell DNA content in multiple myeloma samples using a CD38\/propidium iodide double staining technique","volume":"17","author":"Orfao","year":"1994","journal-title":"Cytometry"},{"key":"10.1016\/j.leukres.2003.09.015_BIB31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood.V86.1.390.bloodjournal861390","article-title":"Transplantation of CD34+ peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma","volume":"86","author":"Schiller","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0025-6196(12)61798-4","article-title":"Detection of malignant cells in the peripheral blood of patients with multiple myeloma: clinical implications and research applications","volume":"69","author":"Witzig","year":"1994","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.leukres.2003.09.015_BIB33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1084\/jem.150.4.792","article-title":"Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B cell differentiation","volume":"150","author":"Kubagawa","year":"1979","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2003.09.015_BIB34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood.V71.4.861.861","article-title":"Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement","volume":"71","author":"Epstein","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1182\/blood.V88.2.622.bloodjournal882622","article-title":"Tumor specific aneuploidy not detected in CD19+ B lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis","volume":"88","author":"McSweeney","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.09.015_BIB36","first-page":"1171","article-title":"Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients","volume":"18","author":"Cassel","year":"1990","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB37","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1365-2141.2002.03529.x","article-title":"Chromosomal aberrations are shared by malignant plasmacells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance","volume":"117","author":"Zojer","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.09.015_BIB38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0889-8588(18)30346-0","article-title":"Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules","volume":"6","author":"Pilarski","year":"1992","journal-title":"Hematol. Oncol. Clin. North Am."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603003205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603003205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T22:03:42Z","timestamp":1585346622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603003205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0145212603003205"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2003.09.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}